Meet Our Featured Speakers

Viral Vectors Summit 2026 is seeking presentations that focus on the following key topics:

• Future viral vector market forecasts and emerging economic trends
• Developing next-generation precision gene therapies with targeted delivery
• Emerging innovations shaping next-generation viral vector technologies
• Enhancing scalability with automated and efficient manufacturing processes
• Patient-first safety strategies guiding viral vector dosing and redosing
• Overcoming regulatory challenges through clinical data harmonization

Viral Vectors Summit 2026 offers scientific and business insights into vector development strategies across therapeutic platforms, with a focus on emerging technologies and the future of clinical care.

Viral Vectors Summit 2026 brings together professionals in gene therapy, virology, biotechnology, and related fields to share achievements and exchange insights. With a strong focus on networking and collaboration, the event fosters discussions on technical advancements in viral vector development for the biopharmaceutical industry. Attendees will have the opportunity to connect with leading biotechnology and pharmaceutical companies and gain valuable insights into emerging technologies and manufacturing techniques in viral vector research.

Presentations highlighting novel viral vector technologies, clinical trial updates, manufacturer case studies, and new market data from current and emerging gene therapy initiatives will be central to this conference, along with other timely and relevant topics.

We invite you to participate in this highly productive event, offering an opportunity to collaborate with industry experts and thought leaders in a rapidly evolving field.